Compounds > pyridostigmine bromide
Page last updated: 2024-08-18

pyridostigmine bromide and Genetic Predisposition

pyridostigmine bromide has been researched along with Genetic Predisposition in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, W; Chou, C; Lee, H; Su, K; Tsai, C1
Abu-Amero, KK; Al-Faky, YH; Beeson, D; Bosley, TM; Kabiraj, M; Omer, MI; Oystreck, DT; Salih, MA; Subahi, EM1
Brower, V1
Shen, ZX1
Bosgraaf, L; Ebstein, RP; Grant, AD; Grisaru, D; Korner, M; Livni, N; Shapira, M; Soreq, H; Tur-Kaspa, I1
Beck, KD; Beldowicz, D; Brennan, FX; Moldow, RL; Ottenweller, JE; Servatius, RJ; Zhu, G1

Reviews

1 review(s) available for pyridostigmine bromide and Genetic Predisposition

ArticleYear
Central nervous system effects from a peripherally acting cholinesterase inhibiting agent: interaction with stress or genetics.
    Annals of the New York Academy of Sciences, 2001, Volume: 933

    Topics: Acetylcholine; Acetylcholinesterase; Animals; Basal Ganglia; Behavior, Animal; Brain Chemistry; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance; Electroshock; Genetic Predisposition to Disease; Genetic Variation; Muscle Contraction; Nerve Tissue Proteins; Persian Gulf Syndrome; Prosencephalon; Pyridostigmine Bromide; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Salivation; Stress, Physiological

2001

Other Studies

5 other study(ies) available for pyridostigmine bromide and Genetic Predisposition

ArticleYear
Myasthenia gravis associated with lupus nephritis.
    Lupus, 2008, Volume: 17, Issue:9

    Topics: Cholinesterase Inhibitors; Fatal Outcome; Female; Genetic Predisposition to Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Pyridostigmine Bromide; Siblings; Thymectomy; Young Adult

2008
Congenital myasthenic syndrome due to homozygous CHRNE mutations: report of patients in Arabia.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2011, Volume: 31, Issue:1

    Topics: Adolescent; Genetic Predisposition to Disease; Homozygote; Humans; Male; Mutation; Myasthenic Syndromes, Congenital; Pyridostigmine Bromide; Receptors, Nicotinic; Saudi Arabia; Siblings; Treatment Outcome; Young Adult

2011
Gulf War syndrome revisited.
    EMBO reports, 2003, Volume: 4, Issue:6

    Topics: Environmental Exposure; Genetic Predisposition to Disease; Humans; Military Medicine; Mutation; Nervous System Diseases; Persian Gulf Syndrome; Pyridostigmine Bromide; Stress, Physiological; Veterans; Warfare

2003
Pyridostigmine bromide and Gulf War syndrome.
    Medical hypotheses, 1998, Volume: 51, Issue:3

    Topics: Acetylcholinesterase; Administration, Oral; Butyrylcholinesterase; Cholinesterase Inhibitors; Gas Poisoning; Genetic Predisposition to Disease; Humans; Inactivation, Metabolic; Models, Biological; Persian Gulf Syndrome; Pyridostigmine Bromide

1998
A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases.
    Human molecular genetics, 2000, May-22, Volume: 9, Issue:9

    Topics: Acetylcholinesterase; Adult; Aged; Alleles; Animals; Base Sequence; Binding Sites; Brain; DNA Mutational Analysis; DNA-Binding Proteins; Enzyme Activation; Female; Gene Deletion; Gene Frequency; Genetic Predisposition to Disease; Genotype; Hematopoietic Stem Cells; Hepatocyte Nuclear Factor 3-beta; Heterozygote; Humans; Hypersensitivity; Male; Mice; Mice, Transgenic; Molecular Sequence Data; Nuclear Proteins; Point Mutation; Polymorphism, Genetic; Promoter Regions, Genetic; Protein Binding; Pyridostigmine Bromide; Transcription Factors; Transcription, Genetic

2000